ADAG
USDAdagene Inc. American Depositary Shares
$1.405-0.185 (-11.635%)
Real-time Price
Healthcare
Biotechnology
China
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.590
High
$1.700
Low
$1.300
Volume
0.09M
Company Fundamentals
Market Cap
66.2M
Industry
Biotechnology
Country
China
Trading Stats
Avg Volume
0.09M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.3Current $1.405High $3.16
Related News
GlobeNewswire
Adagene Announces First Patient Dosed in Randomized Dose Optimization Cohort of the Phase 2 Study of Muzastotug (ADG126) in Combination with KEYTRUDA® (pembrolizumab) in Microsatellite Stable Colorectal Cancer
Phase 2 clinical trial underway with first patient dosed in October to support a clear path to Phase 3 based on previous alignment with FDA Patients randomized to either 10 or 20 mg/kg of muzastotug, in combination with
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.